Antiphospholipid Syndrome
Antiphospholipid Syndrome (APS) is an autoimmune, hypercoagulable state caused by antiphospholipid antibodies interfering with the clot formation. APS leads to both arterial and venous thromboses as well as pregnancy related complications such as miscarriage, stillbirth, preterm delivery and severe preeclampsia. The diagnostic criteria for APS consist of one clinical event (i.e. thrombosis or pregnancy complication) and two antibody blood tests spaced at least three months apart that confirm the presence of either lupus anticoagulants or anti-β2-glycoprotein-I antibodies. As β2-glycoprotein-I antibodies are a subset of anti-cardiolipin antibodies, an anti-cardiolipin assay can be performed as a less specific substitute.
Antiphospholipid Syndrome |
||
| BMD810 | DVVtest 10 | 10 x 2 ML |
| BMD815 | DVVconfirm 5 | 10 x 1 ML |
| BMD815L | DVVconfirm 10 | 10 x 2 ML |
| BMD816A | Latrol LA abnormal Control plasma | 10 x 0,5 ML |
| BMD816N | Latrol LA Normal Control Plasma | 10 x 1 ML |
| BMD824 | Acticlot dPT Dilute Prothrombin Time Test |
Kit 120 screens & 120 confirms |
| BMD825 | DVVtest 25 | 10 x 5 ML |